Lombard Medical Inc (EVARF)
Lombard Medical Inc is a medical technology company focused on endovascular devices for treating aortic aneurysms. Its product portfolio includes Aorfix, an endovascular stent-graft used in abdominal aortic aneurysm procedures, along with the Altura stent-graft system and the Aorflex and IntelliFlex LP delivery systems. The company has commercial activity in the United States, the United Kingdom, Germany, Japan, and other international markets. It sells through a direct sales force and distributors to state- or government-owned hospitals. Founded in 1994 and based in Didcot, United Kingdom, Lombard Medical’s common stock is listed on OTC Markets.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-EVAR.F
|
—
|
—
|
—
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.027 K
|
—
|
—
|
—
|
—
|
—
|
—
|